Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Wood

Showing results (81-90 of 170) with videos related to

Pageof 17
Sort By:
Life Sciences|July 18, 1983
Buspirone: a potential atypical neurolepticP L Wood, N P Nair, S Lal, et al.
Pharmaceutical Research|November 27, 2013
WIN 44,441: A Stereospecific and Long-Acting Narcotic AntagonistP L Wood, C Pilapil, M Thakur, et al.
Neuroscience Letters|May 1, 1979
Cortical lesions modulate turnover rates of acetylcholine and gamma-aminobutyric acidP L Wood, F Moroni, D L Cheney, et al.
Neuropharmacology|November 1, 1987
The endogenous kappa agonist, dynorphin(1-13), does not alter basal or morphine-stimulated dopamine metabolism in the nigrostriatal pathway of the ratP L Wood, H S Kim, C Cosi, et al.
Journal of Neurochemistry|September 1, 1995
Microglial cathepsin B: an immunological examination of cellular and secreted speciesR E Ryan, B F Sloane, M Sameni, et al.
Glia|January 1, 1996
Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell lineC H Park, E Carboni, P L Wood, et al.
Neuropharmacology|January 1, 1989
Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediationP L Wood, H S Kim, W C Boyar, et al.
Brain Research|September 13, 1988
Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine releaseC A Altar, W C Boyar, E Oei, et al.
Life Sciences|January 1, 1988
Dynamics of the striatal 3-MT pool in rat and mouse: species differences as assessed by steady-state measurements and intracerebral dialysisP L Wood, H S Kim, K Stocklin, et al.
Neuroscience|February 1, 1996
A metabotropic glutamate receptor agonist regulates neurotrophin messenger RNA in rat forebrainK D Murray, P L Wood, C Rosasco, et al.
Pageof 17

Showing results (81-90 of 170) with videos related to

Sort By:
Pageof 17
Life Sciences|July 18, 1983
Buspirone: a potential atypical neurolepticP L Wood, N P Nair, S Lal, et al.
Pharmaceutical Research|November 27, 2013
WIN 44,441: A Stereospecific and Long-Acting Narcotic AntagonistP L Wood, C Pilapil, M Thakur, et al.
Neuroscience Letters|May 1, 1979
Cortical lesions modulate turnover rates of acetylcholine and gamma-aminobutyric acidP L Wood, F Moroni, D L Cheney, et al.
Neuropharmacology|November 1, 1987
The endogenous kappa agonist, dynorphin(1-13), does not alter basal or morphine-stimulated dopamine metabolism in the nigrostriatal pathway of the ratP L Wood, H S Kim, C Cosi, et al.
Journal of Neurochemistry|September 1, 1995
Microglial cathepsin B: an immunological examination of cellular and secreted speciesR E Ryan, B F Sloane, M Sameni, et al.
Glia|January 1, 1996
Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell lineC H Park, E Carboni, P L Wood, et al.
Neuropharmacology|January 1, 1989
Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediationP L Wood, H S Kim, W C Boyar, et al.
Brain Research|September 13, 1988
Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine releaseC A Altar, W C Boyar, E Oei, et al.
Life Sciences|January 1, 1988
Dynamics of the striatal 3-MT pool in rat and mouse: species differences as assessed by steady-state measurements and intracerebral dialysisP L Wood, H S Kim, K Stocklin, et al.
Neuroscience|February 1, 1996
A metabotropic glutamate receptor agonist regulates neurotrophin messenger RNA in rat forebrainK D Murray, P L Wood, C Rosasco, et al.
Pageof 17